Simplifying glaucoma medical therapy for our patients
Numerous studies have shown that adherence declines with more complex regimens of more than 1 or 2 bottles.
Aramis Biosciences announces FDA clearance of IND application for A197
According to the company, A197 is a novel, first-in-class, topical immunomodulatory agent which will move into Phase II clinical trials in dry eye patients.
Micro-bypass stent implant during cataract surgery: lower IOP, fewer medications
Mark Gallardo, MD, reports 12-month outcomes of iStent inject® combined with cataract surgery in a predominantly Hispanic patient population with mild to moderate open-angle glaucoma (OAG) and comorbid cataract.
Exploring collagen cross-linking as a treatment for keratoconus
Kathryn M. Hatch, MD, details how collagen CXL is evolving with the goals of reducing complications and actually improving visual acuity.
Study: Dexamethasone intraocular suspension 9% offering high surgeon, patient satisfaction after cataract surgery
Cathleen McCabe, MD, presents results of a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.
Advancements with preloaded IOL injectors
Physician offers practical advice for the use of systems.
Timing and earlier neurolept anesthesia for laser-assisted cataract surgery
Administration has minimal impact on patients’ perception of pain.
App helps patients with cataracts have smoother surgery process
Technology enables physicians to provide and receive important information more quickly.
Cataract surgeons on OR waste: Less is often more
Much of today’s surgical refuse is due to the single use of virtually everything.
IOL dilemma: Replacement or rescue
Investigators find little difference between the options.
Looking at technological advancements in cataract surgery
In recognition of Cataract Awareness Month.
Explaining cataract surgery to patients
Light adjustable IOLs: Treat patients with Star Trek-like technology
Lens option can correct for surgically induced astigmatism or an inaccurate position.
Examining stability of aspheric IOL in cataract patients
Bi-sign design compensates for aberrations resulting from misalignment.
Physician shares first-hand experience as cataract surgery patient
Mark Packer, MD, offers personal insight in honor of Cataract Awareness Month.
Benefits of topography-guided treatments for irregular corneas
Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.
New options are on horizon for presbyopia-correcting drops
Therapeutic choices beneficial for patients may be available in 1 to 3 years.
Predicting laser vision correction results
Investigators examine the demographic, refractive, PRO data measure.
Refractive surgeons report boost in patient interest during the COVID-19 era
Patients are serious about procedure and ready to move forward.
Study examines pairing phacoemulsification, implantation of microbypass stents
Investigators find treatment is an option for treating open-angle glaucoma.
AI enhances customized myopic LASIK with ray tracing optimization
Novel technique provides another option for normal and irregular corneas.
Intracanalicular dexamethasone insert offers hands-free therapy
An alternative to drops, the option provides consistent therapeutic levels.
SMILE offers low enhancement rate after nomogram adjustment
Refractive surgery for treating myopia is linked to low rates of regression, enhancement.
Focus on molecular mechanisms underlying cataract development
Several hundred genes are associated with congenital forms.
Comparable conscious sedation methods address individual patient needs
Sublingual troche sedation represents attractive anesthesia option for specific subset of patients with cataracts.
Light-adjustable IOL offers positive refractive results in patients
New option may prove to be a solution for cataract cases with unusual corneas.
Pearls for optimizing patient outcomes of macular surgery
Early clinical experience with next-generation lens
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S.
A new tool to treat TED
Patients show impressive proptosis and diplopia responses to teprotumumab.
Expert on IFIS offers practical pearls for success
Cataract surgeons must consider medication history as part of preoperative evaluation.
2 Clarke Drive Cranbury, NJ 08512